Wilkinson Global Asset Management’s AbbVie ABBV Stock Holding History

Wilkinson Global Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.41M	Hold	17,542	–	–	0.35%	28
2026 Q1	$3.82M	Sell	17,542 -270	-2%	-$59.9K	0.29%	25
2025 Q4	$4.07M	Buy	17,812 +270	+2%	+$61.5K	0.28%	27
2025 Q3	$4.06M	Sell	17,542 -363	-2%	-$73.9K	0.26%	29
2025 Q2	$3.32M	Sell	17,905 -483	-3%	-$89.8K	0.21%	30
2025 Q1	$3.85M	Sell	18,388 -220	-1%	-$42.8K	0.24%	30
2024 Q4	$3.31M	Sell	18,608 -22	-0.1%	-$4.04K	0.2%	31
2024 Q3	$3.68M	Sell	18,630 -232	-1%	-$43.3K	0.22%	31
2024 Q2	$3.24M	Hold	18,862	–	–	0.2%	31
2024 Q1	$3.43M	Buy	18,862 +750	+4%	+$129K	0.22%	30
2023 Q4	$2.81M	Hold	18,112	–	–	0.19%	31
2023 Q3	$2.7M	Hold	18,112	–	–	0.21%	33
2023 Q2	$2.44M	Sell	18,112 -175	-1%	-$25.7K	0.19%	32
2023 Q1	$2.91M	Sell	18,287 -4,200	-19%	-$642K	0.23%	28
2022 Q4	$3.63M	Hold	22,487	–	–	0.3%	28
2022 Q3	$3.02M	Sell	22,487 -3,540	-14%	-$508K	0.27%	28
2022 Q2	$3.99M	Sell	26,027 -5,008	-16%	-$765K	0.34%	27
2022 Q1	$5.03M	Sell	31,035 -475	-2%	-$69K	0.32%	29
2021 Q4	$4.27M	Buy	31,510 +475	+2%	+$56.1K	0.24%	32
2021 Q3	$3.35M	Sell	31,035 -58	-0.2%	-$6.63K	0.2%	37
2021 Q2	$3.5M	Hold	31,093	–	–	0.21%	36
2021 Q1	$3.37M	Buy	+31,093	New	+$3.33M	0.21%	34

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wilkinson Global Asset Management's ABBV Position: Q2 2026 in Review

Wilkinson Global Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 17,542 shares worth $4.41M. The position accounts for 0.35% of the portfolio, ranked #28.

Wilkinson Global Asset Management first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.03M in Q1 2022. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wilkinson Global Asset Management held 17,542 shares of AbbVie worth $4.41M as of Q2 2026.
Wilkinson Global Asset Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.35% of Wilkinson Global Asset Management's portfolio in Q2 2026, its #28 holding.
Wilkinson Global Asset Management first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
Wilkinson Global Asset Management's AbbVie position peaked at $5.03M in Q1 2022.
4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wilkinson Global Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.